Cardiac Troponin T (cTnT) Peptid
cTnT
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Cardiac Troponin T2 (cTnT) Produkte
- Cardiac Troponin T2 (cTnT) (Cardiac Troponin T (cTnT))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- ESKPKPRSFM PNLVPPKIPD GERVDFDDIH RKRMEKDLNE LQALIEAHFE
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TNNT2 antibody,
Alternative Names: Troponin T Type 2 control peptide, Troponin T Type 2 antibody Blocking Peptide, Anti-Troponin T Type 2 Blocking Peptide, CMH2 Blocking Peptide, CMPD2 Blocking Peptide, MGC3889 Blocking Peptide, TnTC Blocking Peptide, cTnT Blocking Peptide, TNNT2 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- Cardiac Troponin T2 (cTnT) (Cardiac Troponin T (cTnT))
- Hintergrund
- TNNT2 is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration. Mutations in the gene encoding TNNT2 have been associated with familial hypertrophic cardiomyopathy as well as with dilated cardiomyopathy.
- Molekulargewicht
- 35 kDa
-
Sie sind hier:
